Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

South Africa's Aspen agrees initial deal to make J&J vaccine candidate

11/02/2020 | 03:46am EDT
An Aspen Pharmacare logo is seen at outside company offices in Woodmead

JOHANNESBURG (Reuters) - South African pharmaceutical company Aspen Pharmacare said on Monday it had reached a preliminary agreement with Johnson & Johnson to commercially manufacture its COVID-19 vaccine candidate, sending its shares higher.

The country's biggest drugmaker said it had agreed to provide capacity required for the manufacture of J&J's vaccine candidate, which is still in clinical trials, at its Port Elizabeth facility.

The agreement with J&J will see Aspen perform formulation, filling and secondary packaging of the vaccine for the U.S. firm, the company said.

Aspen's shares rose more than 4% on the Johannesburg Stock Exchange on the announcement.

The company said it had invested more than 3 billion rand ($184.2 million) in the Port Elizabeth facility.

"The production area where it is intended that the vaccine candidate will be manufactured has capacity to produce more than 300 million doses per annum," it added.

South Africa has recorded more than 726,000 coronavirus infections, the highest number on the African continent, and more than 19,400 deaths.

It is hosting at least four clinical trials of potential COVID-19 vaccines, including the J&J candidate.

The agreement between Aspen and J&J is subject to the completion of technology transfer activities and finalisation of certain commercial terms.

Last month South Africa's Biovac Institute - a joint venture between the government and private sector - said it was in talks to produce some of the vaccines the country needs to protect itself against COVID-19.

($1 = 16.2888 rand)

(Reporting by Tanisha Heiberg; Editing by Alexander Winning and Emelia Sithole-Matarise)

By Tanisha Heiberg

© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ASPEN PHARMACARE HOLDINGS LIMITED 1.68% 249.08 End-of-day quote.98.68%
DOW JONES AFRICA TITANS 50 INDEX 0.00% 553.88 Delayed Quote.4.55%
DOW JONES SOUTH AFRICA(ZAR) 1.06% 1918.92 Delayed Quote.8.80%
S&P AFRICA 40 INDEX 0.33% 178.65 Delayed Quote.3.12%
Latest news "Companies"
12:27pBANCA MONTE DEI PASCHI DI SIENA S P A : Italy, UniCredit break off talks on ailing Italian bank
12:26p'Dune' Opens to $40 Million at the Box Office. Strong Enough for a Sequel?
12:19pUniCredit, Italy govt end talks over potential sale of Monte dei Paschi
12:16pBANCA MONTE DEI PASCHI DI SIENA S P A : MPS talks stumbled on 2.3/3.5 bln euro valuation gap - source
12:14pEFG HERMES E : ValU, the Leading Buy-Now Pay-Later (BNPL) Fintech Platform, Wins the Fintech Company of the Year Category at the Inaugural Gulf Business Tech Awards 2021
12:06pNIGERIAN BREWERIES : Some Young Nigerians Say Heavy Drinking Is Fun - Controls Must Keep Pace With Culture
12:04pS S LAZIO S P A : Primavera 2 | Lazio-Cesena 4-2, match report
12:03pIndustry Titans, Grant Cardone and Partner, Brandon Dawson, Launch 10X Buy Sell to Create Value and Transform Business Brokerage for the Lower Middle Market
12:01pLooking Glass Labs Engages Meadowbank Strategic Partners to Provide Investor Relations Services
11:57aAeromexico aims higher with sustainable aviation fuel flights
Latest news "Companies"